Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Rauno Mäntyjärvi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Disorders
Anatomy
Concepts & Ideas
Procedures
Genes & Molecular Sequences
Physiology
Sign-in to see full Profile
Network (preview)
35
Virtanen, Tuomas
28
Syrjänen, Kari
21
Rautiainen, Jaakko
17
Syrjänen, Stina
14
Zeiler, Thomas
11
Taivainen, Antti
10
Rytkönen, M
9
Rytkönen-Nissinen, Marja
9
Tosi, Piero
7
Cintorino, Marcella
6
Kauppinen, Juha
4
Saarelainen, Soili
4
Santopietro, Rosa
3
Petracca, Roberto
3
Auriola, Seppo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Rauno Mäntyjärvi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2005: Porre S; Heinonen S; Mäntyjärvi R; Rytkönen-Nissinen M; Perola O; Rautiainen J; Virtanen T
Psoriasin, a calcium-binding protein with chemotactic properties is present in the third trimester amniotic fluid.
Molecular human reproduction 2005;11(2):87-92.
-
2004: Saarelainen S; Taivainen A; Rytkönen-Nissinen M; Auriola S; Immonen A; Mäntyjärvi R; Rautiainen J; Kinnunen T; Virtanen T
Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(10):1576-82.
-
2004: Korpi Anne; Mäntyjärvi Rauno; Rautiainen Jaakko; Kaliste Eila; Kalliokoski Pentti; Renström Anne; Pasanen Anna-Liisa
Detection of mouse and rat urinary aeroallergens with an improved ELISA.
The Journal of allergy and clinical immunology 2004;113(4):677-82.
-
2003: Immonen A; Saarelainen S; Rautiainen J; Rytkönen-Nissinen M; Kinnunen T; Mäntyjärvi R; Virtanen T
Probing the mechanisms of low immunogenicity of a lipocalin allergen, Bos d 2, in a mouse model.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(6):834-41.
-
2003: Kinnunen Tuure; Buhot Cecile; Närvänen Ale; Rytkönen-Nissinen Marja; Saarelainen Soili; Pouvelle-Moratille Sandra; Rautiainen Jaakko; Taivainen Antti; Maillère Bernard; Mäntyjärvi Rauno; Virtanen Tuomas
The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells.
European journal of immunology 2003;33(6):1717-26.
-
2002: Zeiler T; Taivainen A; Mäntyjärvi R; Tukiainen H; Rautiainen J; Rytkönen-Nissinen M; Virtanen T
Threshold levels of purified natural Bos d 2 for inducing bronchial airway response in asthmatic patients.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(10):1454-60.
-
2002: Saarelainen Soili; Zeiler Thomas; Rautiainen Jaakko; Närvänen Ale; Rytkönen-Nissinen Marja; Mäntyjärvi Rauno; Vilja Pekka; Virtanen Tuomas
Lipocalin allergen Bos d 2 is a weak immunogen.
International immunology 2002;14(4):401-9.
-
2001: Rautiainen J; Auriola S; Konttinen A; Virtanen T; Rytkönen-Nissinen M; Zeiler T; Mäntyjärvi R
Two new variants of the lipocalin allergen Bos d 2.
Journal of chromatography. B, Biomedical sciences and applications 2001;763(1-2):91-8.
-
2001: Rouvinen J; Virtanen T; Mäntyjärvi R
Search for the determinants of allergenicity in proteins of the lipocalin family.
Journal of chromatography. B, Biomedical sciences and applications 2001;756(1-2):199-206.
-
2000: Mäntyjärvi R; Rautiainen J; Virtanen T
Lipocalins as allergens.
Biochimica et biophysica acta 2000;1482(1-2):308-17.
-
1999: Virtanen T; Zeiler T; Mäntyjärvi R
Important animal allergens are lipocalin proteins: why are they allergenic?
International archives of allergy and immunology 1999;120(4):247-58.
-
1999: Virtanen T; Zeiler T; Rautiainen J; Mäntyjärvi R
Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself?
Immunology today 1999;20(9):398-400.
-
1999: Kauppinen J; Zeiler T; Rautiainen J; Rytkönen-Nissinen M; Taivainen A; Mäntyjärvi R; Virtanen T
Mutant derivatives of the main respiratory allergen of cow are less allergenic than the intact molecule.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29(7):989-96.
-
1999: Kauppinen J; Mäntyjärvi R; Katila M L
Mycobacterium malmoense-specific nested PCR based on a conserved sequence detected in random amplified polymorphic DNA fingerprints.
Journal of clinical microbiology 1999;37(5):1454-8.
-
1999: Zeiler T; Mäntyjärvi R; Rautiainen J; Rytkönen-Nissinen M; Vilja P; Taivainen A; Kauppinen J; Virtanen T
T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(3):1415-22.
-
1999: Rouvinen J; Rautiainen J; Virtanen T; Zeiler T; Kauppinen J; Taivainen A; Mäntyjärvi R
Probing the molecular basis of allergy. three-dimensional structure of the bovine lipocalin allergen Bos d 2.
The Journal of biological chemistry 1999;274(4):2337-43.
-
1998: Santa H; Saarela J T; Laatikainen R; Rautianen J; Virtanen T; Rytkönen M; Mäntyjärvi R
A bovine dander allergen, comparative modeling, and similarities and differences in folding with related proteins.
Journal of protein chemistry 1998;17(7):657-62.
-
1998: Rautiainen J; Auriola S; Rouvinen J; Kauppinen J; Zeiler T; Novikov D; Virtanen T; Mäntyjärvi R A
Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family.
Biochemical and biophysical research communications 1998;247(3):746-50.
-
1998: Rautiainen J; Rytkönen M; Syrjänen K; Pentikäinen J; Zeiler T; Virtanen T; Mäntyjärvi R
Tissue localization of bovine dander allergen Bos d 2.
The Journal of allergy and clinical immunology 1998;101(3):349-53.
-
1997: Zeiler T; Taivainen A; Rytkönen M; Rautiainen J; Karjalainen H; Mäntyjärvi R; Tuomisto L; Virtanen T
Recombinant allergen fragments as candidate preparations for allergen immunotherapy.
The Journal of allergy and clinical immunology 1997;100(6 Pt 1):721-7.
-
1997: Rautiainen J; Rytkönen M; Virtanen T; Pentikäinen J; Zeiler T; Mäntyjärvi R
BDA20, a major bovine dander allergen characterized at the sequence level, is Bos d 2.
The Journal of allergy and clinical immunology 1997;100(2):251-2.
-
1997: Rautiainen M; Virtanen T; Ruoppi P; Nuutinen J; Mäntyjärvi R
Humoral responses to bovine dust in dairy farmers with allergic rhinitis.
Acta oto-laryngologica. Supplementum 1997;529():169-72.
-
1996: Rautiainen J; Pentikäinen J; Rytkönen M; Linnala-Kankkunen A; Pelkonen J; Virtanen T; Mäntyjärvi R
Molecular analysis of allergenic proteins in bovine dander.
Allergy 1996;51(6):378-82.
-
1996: Mäntyjärvi R; Parkkinen S; Rytkönen M; Pentikäinen J; Pelkonen J; Rautiainen J; Zeiler T; Virtanen T
Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family.
The Journal of allergy and clinical immunology 1996;97(6):1297-303.
-
1996: Syrjänen K; Nurmi T; Mäntyjärvi R; Ilonen J; Syrjänen S; Surcel H M; Yliskoski M; Väyrynen M; Chang F; Saarikoski S
HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.
Cytopathology : official journal of the British Society for Clinical Cytology 1996;7(2):99-107.
-
1996: Virtanen T; Zeiler T; Rautiainen J; Taivainen A; Pentikäinen J; Rytkönen M; Parkkinen S; Pelkonen J; Mäntyjärvi R
Immune reactivity of cow-asthmatic dairy farmers to the major allergen of cow (BDA20) and to other cow-derived proteins. The use of purified BDA20 increases the performance of diagnostic tests in respiratory cow allergy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1996;26(2):188-96.
-
1995: Rautiainen J; Rytkönen M; Parkkinen S; Pentikäinen J; Linnala-Kankkunen A; Virtanen T; Pelkonen J; Mäntyjärvi R
cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin.
The Journal of investigative dermatology 1995;105(5):660-3.
-
1995: Parkkinen S; Rytkönen M; Pentikäinen J; Virtanen T; Mäntyjärvi R
Homology of a bovine allergen and the oligomycin sensitivity-conferring protein of the mitochondrial adenosine triphosphate synthase complex.
The Journal of allergy and clinical immunology 1995;95(6):1255-60.
-
1994: Tervahauta A I; Syrjänen S M; Mäntyjärvi R; Syrjänen K J
Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Cytopathology : official journal of the British Society for Clinical Cytology 1994;5(5):282-93.
-
1994: Ylönen J; Virtanen T; Rytkönen M; Mäntyjärvi R
Quantification of a major bovine allergen by a two-site immunometric assay based on monoclonal antibodies.
Allergy 1994;49(9):707-12.
-
1994: Kauppinen J; Mäntyjärvi R; Katila M L
Random amplified polymorphic DNA genotyping of Mycobacterium malmoense.
Journal of clinical microbiology 1994;32(7):1827-9.
-
1994: Ylönen J; Virtanen T; Horsmanheimo L; Parkkinen S; Pelkonen J; Mäntyjärvi R
Affinity purification of the major bovine allergen by a novel monoclonal antibody.
The Journal of allergy and clinical immunology 1994;93(5):851-8.
-
1993: Kataja V; Syrjänen S; Yliskoski M; Hippelïnen M; Väyrynen M; Saarikoski S; Mäntyjärvi R; Jokela V; Salonen J T; Syrjänen K
Risk factors associated with cervical human papillomavirus infections: a case-control study.
American journal of epidemiology 1993;138(9):735-45.
-
1993: Tosi P; Pallini V; Cintorino M; Bugnoli M; Covacci A; Petracca R; Syrjänen S; Del Vecchio M T; Mäntyjärvi R; Ruggiero P
Use of antibodies against a synthetic peptide of the E6 protein of human papillomavirus (HPV) type 16 for the diagnosis of genital HPV lesions.
Cytopathology : official journal of the British Society for Clinical Cytology 1993;4(1):3-15.
-
1992: Rautiainen M; Ruoppi P; Jägerroos H; Nuutinen J; Mäntyjärvi R; Virtanen T
Nasal sensitization of dairy farmers to bovine epithelial and urinary antigens.
Rhinology 1992;30(2):121-7.
-
1992: Kataja V; Syrjänen S; Mäntyjärvi R; Yliskoski M; Saarikoski S; Syrjänen K
Prognostic factors in cervical human papillomavirus infections.
Sexually transmitted diseases 1992;19(3):154-60.
-
1992: Yliskoski M; Tervahauta A; Saarikoski S; Mäntyjärvi R; Syrjänen K
Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.
Sexually transmitted diseases 1992;19(3):137-9.
-
1992: Ylönen J; Mäntyjärvi R; Taivainen A; Virtanen T
IgG and IgE antibody responses to cow dander and urine in farmers with cow-induced asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1992;22(1):83-90.
-
1992: Virtanen T; Eskelinen T; Husman K; Mäntyjärvi R
Long- and short-term variability of airborne bovine epithelial antigen concentrations in cowsheds.
International archives of allergy and immunology 1992;98(3):252-5.
-
1992: Laatikainen A; Schultz-Suhonen L; Mäntyjärvi R
Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1992;35(3):205-10.
-
1992: Ylönen J; Mäntyjärvi R; Taivainen A; Virtanen T
Comparison of the antigenic and allergenic properties of three types of bovine epithelial material.
International archives of allergy and immunology 1992;99(1):112-7.
-
1991: Kärkkäinen U; Ikäheimo R; Katila M L; Mäntyjärvi R
P fimbriation of Escherichia coli strains from patients with urosepsis demonstrated by a commercial agglutination test (PF TEST).
Journal of clinical microbiology 1991;29(1):221-4.
-
1990: Laatikainen A; Sarkkinen H; Syrjänen K; Mäntyjärvi R
Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(10):909-15.
-
1990: Virtanen T; Kalliokoski P; Vilhunen P; Taivainen A; Mäntyjärvi R
Concentrations of specific dusts in swineries and the humoral response of swinery workers.
Allergy 1990;45(5):354-62.
-
1990: Kataja V; Syrjänen K; Syrjänen S; Mäntyjärvi R; Yliskoski M; Saarikoski S; Salonen J T
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data.
European journal of epidemiology 1990;6(1):9-14.
-
1990: Ylönen J; Nuutinen J; Rautiainen M; Ruoppi P; Mäntyjärvi R; Virtanen T
Comparative analysis of bovine extracts by immunoblotting and ELISA inhibition. Rabbit and human responses against cow epithelial and urine antigens.
Allergy 1990;45(1):30-9.
-
1990: Laatikainen A; Karjalainen H; Jägerroos H; Sarkkinen H; Mäntyjärvi R
Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.
Cancer immunology, immunotherapy : CII 1990;31(3):164-8.
-
1990: Laatikainen A; Karjalainen H; Sarkkinen H; Syrjänen K; Mäntyjärvi R
Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.
Cancer immunology, immunotherapy : CII 1990;30(6):351-6.
-
1990: Leoncini P; Petracca R; Ruggiero P; Cintorino M; Syrjänen S; Mäntyjärvi R; Syrjänen K
Expression of cytokeratin No. 19 polypeptide in genital papillomavirus lesions.
Gynecologic and obstetric investigation 1990;29(1):59-66.
-
1989: Mäntyjärvi M; Syrjänen S; Kaipiainen S; Mäntyjärvi R; Kahlos T; Syrjänen K
Detection of human papillomavirus type 11 DNA in a conjunctival squamous cell papilloma by in situ hybridization with biotinylated probes.
Acta ophthalmologica 1989;67(4):425-9.
-
1989: Parkkinen S; Mäntyjärvi R; Syrjänen K; Syvänen A C; Ranki M
Sandwich hybridization in solution: a rapid method to screen HPV 16 DNA in cervical scrapes.
Molecular and cellular probes 1989;3(1):1-11.
-
1989: Kataja V; Syrjänen K; Mäntyjärvi R; Väyrynen M; Syrjänen S; Saarikoski S; Parkkinen S; Yliskoski M; Salonen J T; Castren O
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.
European journal of epidemiology 1989;5(1):1-7.
-
1989: Syrjänen K; Syrjänen S; Kellokoski J; Kärjä J; Mäntyjärvi R
Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization.
Lung 1989;167(1):33-42.
-
1988: Syrjänen K; Mäntyjärvi R; Saarikoski S; Väyrynen M; Syrjänen S; Parkkinen S; Yliskoski M; Saastamoinen J; Castren O
Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up.
British journal of obstetrics and gynaecology 1988;95(11):1096-102.
-
1988: Parkkinen S; Syrjänen S; Syrjänen K; Yliskoski M; Tenhunen J; Mäntyjärvi R; Ranki M
Screening of premalignant cervical lesions for HPV 16 DNA by sandwich and in situ hybridization techniques.
Gynecologic oncology 1988;30(2):251-64.
-
1988: Syrjänen S; Partanen P; Mäntyjärvi R; Syrjänen K
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.
Journal of virological methods 1988;19(3-4):225-38.
-
1988: Virtanen T; Vilhunen P; Husman K; Happonen P; Mäntyjärvi R
Level of airborne bovine epithelial antigen in Finnish cowsheds.
International archives of occupational and environmental health 1988;60(5):355-60.
-
1988: Virtanen T; Vilhunen P; Husman K; Mäntyjärvi R
Sensitization of dairy farmers to bovine antigens and effects of exposure on specific IgG and IgE titers.
International archives of allergy and applied immunology 1988;87(2):171-7.
-
1988: Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Intervirology 1988;29(6):311-9.
-
1988: Tosi P; Luzi P; Santopietro R; Miracco C; Lio R; Syrjänen S; Mäntyjärvi R; Syrjänen K
Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix.
Applied pathology 1988;6(4):247-57.
-
1988: Mäntyjärvi R; Sarkkinen H; Parkkinen S; Ryhänen A; Karjalainen H; Syrjänen K; Syrjänen S
Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.
Archives of virology 1988;100(1-2):17-25.
-
1988: Cintorino M; Syrjänen S; Leoncini P; Bellizzi De Marco E; Petracca R; Pallini V; Tosi P; Mäntyjärvi R; Syrjänen K
Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix.
Archives of gynecology and obstetrics 1988;241(4):235-47.
-
1988: Syrjänen S; Cintorino M; Armellini D; Del Vecchio M T; Leoncini P; Bugnoli M; Pallini V; Silvestri S; Tosi P; Mäntyjärvi R
Expression of cytokeratin polypeptides in human papillomavirus (HPV) lesions of the uterine cervix: 1. Relationship to grade of CIN and HPV type.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1988;7(1):23-38.
-
1987: Syrjänen K J; Mäntyjärvi R; Väyrynen M; Yliskoski M; Syrjänen S M; Saarikoski S; Nurmi T; Parkkinen S; Castrén O
Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women.
Acta cytologica 1987;31(6):855-65.
-
1987: Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
Archiv für Geschwulstforschung 1987;57(4):265-74.
-
1987: Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
Neoplasma 1987;34(4):431-9.
-
1987: Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
Archiv für Geschwulstforschung 1987;57(1):7-15.
-
1987: Syrjänen K; Mäntyjärvi R; Väyrynen M; Syrjänen S; Parkkinen S; Yliskoski M; Saarikoski S; Castrén O
Evolution of human papillomavirus infections in the uterine cervix during a long-term prospective follow-up.
Applied pathology 1987;5(2):121-35.
-
1986: Parkkinen S; Mäntyjärvi R; Syrjänen K; Ranki M
Detection of human papillomavirus DNA by the nucleic acid sandwich hybridization method from cervical scraping.
Journal of medical virology 1986;20(3):279-88.
-
1986: Syrjänen K; Tosi P; Cintorino M; Mäntyjärvi R; Luzi P; Leoncini L; Laatikainen A; Miracco C; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood.
Experimental pathology 1986;30(2):75-82.
-
1986: Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
Experimental pathology 1986;30(2):65-74.
-
1986: Syrjänen K; Väyrynen M; Mäntyjärvi R; Holopainen H; Saarikoski S; Syrjänen S; Parkkinen S; Castrén O
Electron microscopy in assessment of the biological behavior of human papillomavirus infections in the uterine cervix.
Neoplasma 1986;33(4):493-505.
-
1986: Syrjänen S; Syrjänen K; Mäntyjärvi R; Parkkinen S; Väyrynen M; Saarikoski S; Castren O
Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies.
Archives of gynecology 1986;239(1):39-48.
-
1986: Syrjänen K; Väyrynen M; Mäntyjärvi R; Castren O; Saarikoski S
Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions.
Acta obstetricia et gynecologica Scandinavica 1986;65(2):139-45.
-
1985: Syrjänen K; Väyrynen M; Saarikoski S; Mäntyjärvi R; Parkkinen S; Hippeläinen M; Castren O
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up.
British journal of obstetrics and gynaecology 1985;92(11):1086-92.
-
1985: Väyrynen M; Syrjänen K; Castrén O; Saarikoski S; Mäntyjärvi R
Colposcopy in women with papillomavirus lesions of the uterine cervix.
Obstetrics and gynecology 1985;65(3):409-15.
-
1985: Syrjänen K; de Villiers E M; Saarikoski S; Castren O; Väyrynen M; Mäntyjärvi R; Parkkinen S
Cervical papillomavirus infection progressing to invasive cancer in less than three years.
Lancet 1985;1(8427):510-1.
-
1985: Syrjänen K; Mäntyjärvi R; Väyrynen M; Holopainen H; Saarikoski S; Castrén O
Factors influencing the biological behaviour of cervical human papillomavirus (HPV) infections in prospectively followed-up women.
Archiv für Geschwulstforschung 1985;55(6):457-66.
-
1985: Syrjänen K; Mäntyjärvi R; Väyrynen M; Castrén O; Yliskoski M; Saarikoski S
Chlamydial cervicitis in women followed-up for human papillomavirus (HPV) lesions of the uterine cervix.
Acta obstetricia et gynecologica Scandinavica 1985;64(6):467-71.
-
1985: Syrjänen K; Väyrynen M; Mäntyjärvi R; Saarikoski S; Castrén O
[Human papillomavirus (HPV) and carcinoma of the uterine cervix]
Duodecim; lääketieteellinen aikakauskirja 1985;101(10):959-68.
-
1985: Syrjänen K; Väyrynen M; Hippeläinen M; Castrén O; Saarikoski S; Mäntyjärvi R
Electron microscopic assessment of cervical punch biopsies in women followed-up for human papillomavirus (HPV) lesions.
Archiv für Geschwulstforschung 1985;55(2):131-8.
-
1985: Syrjänen K; Väyrynen M; Hippeläinen M; Castrén O; Saarikoski S; Mäntyjärvi R
The in situ immunological reactivity and its significance in the clinical behavior of the cervical human papillomavirus lesions.
Neoplasma 1985;32(2):181-90.
-
1984: Väyrynen M; Syrjänen K; Mäntyjärvi R; Castrén O; Saarikoski S
Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1984;22(5):375-83.
-
1984: Syrjänen K; Väyrynen M; Castrén O; Mäntyjärvi R; Yliskoski M
The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.
Archives of gynecology 1984;234(3):189-96.
-
1983: Syrjänen K; Väyrynen M; Castrén O; Mäntyjärvi R; Pyrhönen S; Yliskoski M
Morphological and immunohistochemical evidence of human papilloma virus (HPV) involvement in the dysplastic lesions of the uterine cervix.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1983;21(4):261-9.
-
1983: Haikala O J; Kokkonen J O; Leinonen M K; Nurmi T; Mäntyjärvi R; Sarkkinen H K
Rapid detection of rotavirus in stool by latex agglutination: comparison with radioimmunoassay and electron microscopy and clinical evaluation of the test.
Journal of medical virology 1983;11(2):91-7.
Sign-in to see more